Analyze Diet
Animal genetics2008; 40(1); 94-96; doi: 10.1111/j.1365-2052.2008.01778.x

A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses.

Abstract: Glycogen storage diseases or glycogenoses are inherited diseases caused by abnormalities of enzymes that regulate the synthesis or degradation of glycogen. Deleterious mutations in many genes of the glyco(geno)lytic or the glycogenesis pathways can potentially cause a glycogenosis, and currently mutations in fourteen different genes are known to cause animal or human glycogenoses, resulting in myopathies and/or hepatic disorders. The genetic bases of two forms of glycogenosis are currently known in horses. A fatal neonatal polysystemic type IV glycogenosis, inherited recessively in affected Quarter Horse foals, is due to a mutation in the glycogen branching enzyme gene (GBE1). A second type of glycogenosis, termed polysaccharide storage myopathy (PSSM), is observed in adult Quarter Horses and other breeds. A severe form of PSSM also occurs in draught horses. A mutation in the skeletal muscle glycogen synthase gene (GYS1) was recently reported to be highly associated with PSSM in Quarter Horses and Belgian draught horses. This GYS1 point mutation appears to cause a gain-of-function of the enzyme and to result in the accumulation of a glycogen-like, less-branched polysaccharide in skeletal muscle. It is inherited as a dominant trait. The aim of this work was to test for possible associations between genetic polymorphisms in four candidate genes of the glycogen pathway or the GYS1 mutation in Cob Normand draught horses diagnosed with PSSM by muscle biopsy.
Publication Date: 2008-09-24 PubMed ID: 18822097DOI: 10.1111/j.1365-2052.2008.01778.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates how a mutation in the GYS1 gene is largely linked to a disease known as polysaccharide storage myopathy (PSSM) in Cob Normand draught horses. The study aims to examine the potential associations between genetic differences in four potential genes of the glycogen pathway, including the GYS1 mutation, in horses diagnosed with PSSM.

Introduction

  • Glycogen storage diseases, or glycogenoses, are inherited diseases caused by irregularities in enzymes that control the synthesis or degradation of glycogen, a form of sugar stored in the body for energy.
  • These can occur from harmful mutations in multiple genes in the glycolytic or glycogenesis pathways. At present, mutations in fourteen different genes are known of that cause animal or human glycogenoses.
  • The diseases often result in myopathies, which are diseases of the muscle tissue, and/or disorders of the liver.

Glycogenosis in Horses

  • In horses, two forms of glycogenosis are presently identified.
  • A fatal form known as type IV glycogenosis affects neonatal Quarter Horse foals. This form is inherited recessively, meaning both parents must carry the gene to transmit the disorder. This disease is due to a mutation in the glycogen branching enzyme gene (GBE1).
  • Another form of glycogenosis, polysaccharide storage myopathy (PSSM), is observed more commonly in adult Quarter Horses and other breeds. PSSM is said to be severe in draught horses.

Research Aims and Methodology

  • The research aims to explore the link between the GYS1 gene mutation and the case of PSSM in Cob Normand draught horses specifically.
  • The mutation in the GYS1 gene appears to result in an overactive enzyme which leads to the buildup of a less-branched polysaccharide, similar to glycogen, in skeletal muscle. This is inherited as a dominant trait.
  • The study tests for potential associations between genetic variations in four possible genes of the glycogen pathway or the GYS1 mutation in Cob Normand draught horses identified with PSSM through muscle biopsy.

Cite This Article

APA
Herszberg B, McCue ME, Larcher T, Mata X, Vaiman A, Chaffaux S, Chérel Y, Valberg SJ, Mickelson JR, Guérin G. (2008). A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses. Anim Genet, 40(1), 94-96. https://doi.org/10.1111/j.1365-2052.2008.01778.x

Publication

ISSN: 1365-2052
NlmUniqueID: 8605704
Country: England
Language: English
Volume: 40
Issue: 1
Pages: 94-96

Researcher Affiliations

Herszberg, B
  • INRA, UR339, Laboratoire de Génétique Biochimique et de Cytogénétique, Centre de Recherches de Jouy, 78350 Jouy-en-Josas, France. herszberg@ifrance.com
McCue, M E
    Larcher, T
      Mata, X
        Vaiman, A
          Chaffaux, S
            Chérel, Y
              Valberg, S J
                Mickelson, J R
                  Guérin, G

                    MeSH Terms

                    • 1,4-alpha-Glucan Branching Enzyme / genetics
                    • Animals
                    • Carbohydrate Metabolism, Inborn Errors / genetics
                    • Carbohydrate Metabolism, Inborn Errors / pathology
                    • Carbohydrate Metabolism, Inborn Errors / veterinary
                    • Female
                    • Genetic Predisposition to Disease
                    • Glycogen Storage Disease / genetics
                    • Glycogen Storage Disease / veterinary
                    • Glycogen Synthase / genetics
                    • Horse Diseases / genetics
                    • Horse Diseases / pathology
                    • Horses
                    • Muscle, Skeletal / pathology

                    Citations

                    This article has been cited 3 times.
                    1. Hannah WB, Derks TGJ, Drumm ML, Grünert SC, Kishnani PS, Vissing J. Glycogen storage diseases. Nat Rev Dis Primers 2023 Sep 7;9(1):46.
                      doi: 10.1038/s41572-023-00456-zpubmed: 37679331google scholar: lookup
                    2. Maile CA, Hingst JR, Mahalingan KK, O'Reilly AO, Cleasby ME, Mickelson JR, McCue ME, Anderson SM, Hurley TD, Wojtaszewski JFP, Piercy RJ. A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase. Biochim Biophys Acta Gen Subj 2017 Jan;1861(1 Pt A):3388-3398.
                      doi: 10.1016/j.bbagen.2016.08.021pubmed: 27592162google scholar: lookup
                    3. Brosnahan MM, Brooks SA, Antczak DF. Equine clinical genomics: A clinician's primer. Equine Vet J 2010 Oct;42(7):658-70.